{
    "clinical_study": {
        "@rank": "16843", 
        "brief_summary": {
            "textblock": "To determine the safety and tolerance of low-dose versus high-dose cysteamine administered\n      concurrently with zidovudine (AZT). To determine the pharmacokinetics and effects on immune\n      function and viral load in patients receiving these drug regimens."
        }, 
        "brief_title": "A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients receive high or low doses of cysteamine plus AZT or placebo plus AZT. The target\n      dose of cysteamine is determined by titration of the dose over a 6-week period, after which\n      the patient receives 24 additional weeks of treatment. An initial cohort of 36 patients will\n      be enrolled in a 10-week pilot phase. Accrual will be temporarily suspended while data from\n      the pilot phase is assessed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Chemoprophylaxis for Pneumocystis carinii pneumonia, candidiasis, Mycobacterium\n             tuberculosis, and herpes as prescribed by the investigator.\n\n          -  Recombinant erythropoietin and G-CSF if clinically indicated.\n\n        Patients must have:\n\n          -  Documented HIV infection.\n\n          -  CD4 count 300 - 500 cells/mm3.\n\n          -  Prior AZT therapy for at least 3 months but less than 12 months prior to study entry.\n\n          -  No past or current AIDS-defining opportunistic infection.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Kaposi's sarcoma requiring systemic therapy.\n\n          -  Active malignancy other than basal cell carcinoma or in situ cervical carcinoma.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Antiretroviral therapy other than AZT.\n\n          -  Immunosuppressive drugs.\n\n          -  Investigational HIV drugs/therapies other than study drug.\n\n          -  Interferon.\n\n          -  Steroids.\n\n          -  Hematopoietins.\n\n          -  Cytotoxic chemotherapy including Adriamycin, bleomycin, and vincristine.\n\n        Concurrent Treatment:\n\n        Excluded:\n\n          -  Radiation therapy.\n\n        Patients with the following prior condition are excluded:\n\n        History of treatment-limiting intolerance to 500-600 mg AZT daily as manifested by the\n        same recurrent grade 3 toxicity or any prior grade 4 toxicity.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Prior antiretroviral therapy other than AZT.\n\n        Required:\n\n          -  AZT for at least 3 months but no more than 12 months prior to study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "300", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002110", 
            "org_study_id": "211A", 
            "secondary_id": "CYST-9304"
        }, 
        "intervention": [
            {
                "intervention_name": "Cysteamine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Zidovudine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cysteamine", 
                "Zidovudine"
            ]
        }, 
        "keyword": [
            "Drug Therapy, Combination", 
            "AIDS-Related Complex", 
            "Zidovudine", 
            "Cysteamine"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33614"
                    }, 
                    "name": "Infectious Disease Research Institute Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "701122699"
                    }, 
                    "name": "Tulane Univ Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stony Brook", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "117948153"
                    }, 
                    "name": "SUNY / Health Sciences Ctr at Stony Brook"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "271571042"
                    }, 
                    "name": "Bowman Gray School of Medicine / North Carolina Baptist Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cranston", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "02910"
                    }, 
                    "name": "Independent Research Nurses Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75235"
                    }, 
                    "name": "Univ of Texas Southwestern Med Ctr of Dallas"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002110"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mylan Laboratories", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 1995"
    }, 
    "geocoordinates": {
        "Bowman Gray School of Medicine / North Carolina Baptist Hosp": "36.1 -80.244", 
        "Independent Research Nurses Inc": "41.78 -71.437", 
        "Infectious Disease Research Institute Inc": "27.951 -82.457", 
        "SUNY / Health Sciences Ctr at Stony Brook": "40.926 -73.141", 
        "Tulane Univ Med School": "29.951 -90.072", 
        "Univ of Texas Southwestern Med Ctr of Dallas": "32.803 -96.77"
    }
}